Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

DANIMER SCIENTIFIC, INC.

(DNMR)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Danimer Scientific, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021

11/15/2021 | 05:17pm EST

Danimer Scientific, Inc. reported earnings results for the third quarter and nine months ended September 30, 2021. For the third quarter, the company reported revenue was USD 13.37 million compared to USD 12.84 million a year ago. Net income was USD 7.83 million compared to net loss of USD 2.14 million a year ago. Basic earnings per share from continuing operations was USD 0.08 compared to basic loss per share from continuing operations of USD 0.07 a year ago. Diluted earnings per share from continuing operations was USD 0.08 compared to diluted loss per share from continuing operations of USD 0.07 a year ago. For the nine months, revenue was USD 41.02 million compared to USD 35.31 million a year ago. Net loss was USD 47.66 million compared to USD 5.62 million a year ago. Basic loss per share from continuing operations was USD 0.53 compared to USD 0.2 a year ago. Diluted loss per share from continuing operations was USD 0.53 compared to USD 0.2 a year ago.


ę S&P Capital IQ 2021
All news about DANIMER SCIENTIFIC, INC.
01/11SHAREHOLDER ALERT : Robbins LLP is Investigating Danimer Scientific, Inc. (DNMR, DNMRWS) o..
BU
01/11Danimer Scientific to Attend the CJS Securities 22nd Annual New Ideas for the New Year ..
BU
2021DANIMER SCIENTIFIC, INC. : Entry into a Material Definitive Agreement, Creation of a Direc..
AQ
2021DANIMER SCIENTIFIC : Submission of Matters to a Vote of Security Holders - Form 8-K
PU
2021DANIMER SCIENTIFIC, INC. : Submission of Matters to a Vote of Security Holders (form 8-K)
AQ
2021DANIMER SCIENTIFIC : $200 Million Convertible Senior Notes Offering - Form 8-K
PU
2021DANIMER SCIENTIFIC, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
2021Danimer Scientific Prices Upsized $200 Million Debt Offering
MT
2021Danimer Scientific Prices Upsized $200 Million Convertible Senior Notes Offering
BU
2021Wall Street Sees Higher Open as Fed Moves to Boost Taper Pace
MT
More news
Analyst Recommendations on DANIMER SCIENTIFIC, INC.
More recommendations
Financials (USD)
Sales 2021 62,5 M - -
Net income 2021 -93,1 M - -
Net Debt 2021 116 M - -
P/E ratio 2021 -6,51x
Yield 2021 -
Capitalization 666 M 666 M -
EV / Sales 2021 12,5x
EV / Sales 2022 4,40x
Nbr of Employees 190
Free-Float -
Chart DANIMER SCIENTIFIC, INC.
Duration : Period :
Danimer Scientific, Inc. Technical Analysis Chart | DNMR | US2362721001 | MarketScreener
Technical analysis trends DANIMER SCIENTIFIC, INC.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 3
Last Close Price 6,64 $
Average target price 25,33 $
Spread / Average Target 282%
EPS Revisions
Managers and Directors
Stephen E. Croskrey Chairman & Chief Executive Officer
John A. Dowdy Chief Financial Officer
Phillip van Trump Chief Science & Technology Officer
Michael Smith Chief Operating Officer
Isao Noda Independent Director
Sector and Competitors